Improving the Management of Patients with Severe Uncontrolled Asthma

View Activity

PROGRAM CHAIR

Nicola Alexander Hanania, MD, MS
Director, Airways Clinical Research Center
Pulmonary, Critical Care, and Sleep Medicine
Houston, Texas

FACULTY

Sandra G Adams, MD
Professor
University of Texas School of Medicine
San Antonio, Texas

PROGRAM OVERVIEW

This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with uncontrolled asthma.

TARGET AUDIENCE

This CME initiative is designed to meet the educational needs of pulmonologists, allergists, immunologists, and otolaryngologists involved in the healthcare of patients with severe uncontrolled asthma.

LEARNING OBJECTIVES

Upon completion of the program, attendees should be able to:

  • Describe the risk factors that predispose military personnel to asthma and best practices to improve clinical outcomes in veterans
  • Identify the inflammatory profiles associated with different asthma phenotypes and their relevance in developing novel treatments for severe uncontrolled asthma
  • Review evidence supporting the utility of phenotype- and endotype-specific biomarkers in diagnosing, classifying, and controlling severe asthma
  • Create treatment plans individualized for patients with severe uncontrolled asthma that account for specific patient factors, evidence-based guidelines, and the clinical profiles of available treatment options

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

This program would be beneficial for nurses involved in the treatment and management of patients with uncontrolled asthma.
CNE Credits: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education for RNs and APNs.

ONCC STATEMENT

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

DISCLOSURE POLICY STATEMENT

Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Nicola Alexander Hanania, MD, MS reports that he has served as a consultant for GlaxoSmithKline, Novartis, Astra Zeneca, Boehringer Ingelheim, Genentech, Sanofi Genzyme, and Mylan. In addition, he has received research funding from GlaxoSmithKline, AstraZeneca, Novartis, Sanofi, Genentech, and Boehringer Ingelheim.

Dr. Hanania has served on speaker’s bureau for Astra Zeneca.

Dr. Sandra Adams reports that she has received research funding from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mylan/Theravance, Novartis, and Sunovion

CME Content Review
The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.

Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.

Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.

Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group has nothing

Sharine Griggs, Program Manager for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, Dr. Wechsler may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME/CNE credit for this live activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the live activity.
3. Complete pre-and-post survey.
4. Submit the evaluation form to meeting coordinator for processing.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

RELEASE DATE: December 12, 2019

EXPIRATION DATE: December 12, 2020

View Activity

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.